NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +165 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Metastatic Merkel Cell Carcinoma
Explore clinical trials studying Metastatic Merkel Cell Carcinoma. Study availability and eligibility vary by location and protocol.
8 public trials
2 recruiting studies
Metastatic Merkel Cell Carcinoma trial results
NCT05896839
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +34 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Keck Medicine of USC Koreatown Los Angeles, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
Not Yet Recruiting
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
NCT07576725
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +119 more
- Locations
-
- Uganda Cancer Institute Kampala, Uganda
NCT03304639
- Conditions
- Adenocarcinoma, Advanced Merkel Cell Carcinoma, Carcinoma, +21 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
NCT03599713
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
- Locations
-
- Stanford Cancer Institute Palo Alto, California, United States
- University of California San Francisco Comprehensive Cancer Center San Francisco, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Georgetown University Hospital Washington D.C., District of Columbia, United States
Active, Not Recruiting
Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial
NCT05947500
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +19 more
- Locations
-
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Keck Medicine of USC Koreatown Los Angeles, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
Active, Not Recruiting
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
NCT03816332
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +42 more
- Locations
-
- Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Northwestern University Chicago, Illinois, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
Active, Not Recruiting
Targeted Therapy and Avelumab in Merkel Cell Carcinoma
NCT04261855
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
- Locations
-
- Mid North Coast Cancer Institute - Coffs Harbour Health Campus Coffs Harbour, New South Wales, Australia
- Lake Macquarie Private Hospital Gateshead, New South Wales, Australia
- Gosford Hospital Gosford, New South Wales, Australia
- Wyong Hospital Hamlyn Terrace, New South Wales, Australia